98.6% purity
GLP-1 Agonists
Tirzepatide 30mg
Tirzepatide 30mg — dual GIP/GLP-1 receptor agonist. ≥98.6% purity (HPLC-verified). Our higher-dose format for extended metabolic and incretin receptor research programs requiring multiple experimental runs. Ideal for longitudinal dose-escalation protocols. Lyophilised. UK stock.
Bundle & save
🚚 Free UK shipping over £100 · dispatched next business day · 🔔 Get stock alerts
- ✓ Independently HPLC + MS verified — per-batch Certificate of Analysis
- ✓ Pay by Bank (Fena / Wallid) or bank transfer (BACS)
⚠ For laboratory research use only. Not for human or veterinary use. Must be 21+ to purchase.
Tirzepatide 30mg is a 39-amino acid synthetic peptide that acts as a dual receptor agonist (GLP-1 and GIP receptors). It is supplied as a 30mg lyophilized powder with 98.6% purity for laboratory research use. This peptide is extensively studied in scientific contexts for its roles in glucose metabolism, appetite regulation, and energy homeostasis pathways.
Key Details
- Quantity: 30mg per vial
- Form: Lyophilized powder (requires reconstitution for research applications)
- Purity: 98.6% (HPLC verified)
- Intended Use: For research purposes only — not for human consumption, diagnostic, therapeutic, or any other non-laboratory use.
Important Compliance Note This product is sold strictly for in vitro or laboratory research. It has not been approved by the FDA (or equivalent regulatory bodies) for human use. Always follow all applicable laws and institutional guidelines when conducting research. Suitable for qualified researchers and institutions studying incretin biology, metabolic disorders, and related fields.
Chemical Compound Information
- Chemical Name: Tirzepatide (LY3298176)
- Sequence: A 39-amino acid peptide with a C20 fatty diacid moiety attached via a linker (exact sequence includes specific modifications for dual agonism).
- Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈ (approximate)
- Molecular Weight: Approximately 4,813.5 Da
- Classification: Synthetic dual incretin receptor agonist peptide
- CAS Number: 2023788-19-2
Area of Interest Laboratory studies of Tirzepatide have investigated a variety of promising areas:
- Glucose & Insulin Regulation: Explored for its potent effects on insulin secretion and blood glucose control via GLP-1 and GIP pathways.
- Appetite & Weight Management: Studied for significant impacts on food intake, satiety, and body weight in preclinical models.
- Metabolic Health: Investigated in models of obesity, type 2 diabetes, and lipid metabolism.
- Incretin System Research: Used to understand synergistic effects of dual GIP/GLP-1 receptor activation.
Technical Specifications
- Quantity: 30mg
- Form: Lyophilized powder
- Purity: 98.6% (HPLC)
- COA: Provided with each batch (includes HPLC chromatogram and mass spectrometry identity confirmation)
Storage Guidelines
- Lyophilized peptide is stable at room temperature for short periods.
- For long-term storage, keep at −20°C or below.
- Once reconstituted, store at 2–8 °C and use within the recommended research timeframe.
Independent lab verification: View the batch certificate (COA) for this peptide →